Novavax Inc has 10 Schedule 13D or 13G filings on record since 2025-10-14. 3 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.
Stated intent
Intent stated in Item 4 Shah Capital Management
Item 4 is hereby amended to add the following: On April 8, 2026, the Reporting Persons sent a letter (the "Shah Capital Open Letter") to the board of directors of the Issuer (the "Board") declaring a notice of intention to vote against Board Nominees and Executive Compensation.From Item 4 of the SCHEDULE 13D/A filed 2026-04-08
Intent stated in Item 4 Shah Capital Management
Item 4 is hereby amended to add the following: On October 13, 2025, the Reporting Persons sent a letter (the "Shah Capital NVAX BOD Letter") to the board of directors of the Issuer (the "Board") urging the Board to undertake a formal strategic review, including an evaluation of a potential sale of the Issuer.From Item 4 of the SCHEDULE 13D/A filed 2025-10-14
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Shah Capital Management | 9.03% | 14,714,705 | SCHEDULE 13D/A, 2026-05-15 | 2026-05-14 |
| State Street Corporation | 7.1% | 11,740,566 | SCHEDULE 13G, 2026-08-07 | 2026-06-30 |
| Vanguard Capital Management | 5.09% | 8,305,681 | SCHEDULE 13G, 2026-04-30 | 2026-03-31 |
| Bank Of America Corp | 4.1% | 6,655,398 | SCHEDULE 13G/A, 2026-04-27 | 2026-03-31 |
| The Vanguard Group | 0% | 0 | SCHEDULE 13G/A, 2026-03-27 | 2026-03-13 |
Purpose of Transaction (Item 4)
Shah Capital Management
Item 4 is hereby amended to add the following: On May 14, 2026, the Reporting Persons sent a presentation (the "Elevating Novavax Presentation") to the board of directors of the Issuer (the "Board") outlining what they believe to be the failures of the current leadership, specifically noting the following: (i) marketing failure since 2023; (ii) underwhelming Sanofi partnership; (iii) capital market mismanagement; and (iv) leadership enriching itself instead of building value. The foregoing description of the Elevating Novavax Presentation does not purport to be complete and is qualified in its entirety to the Elevating Novavax Presentation, which is attached hereto as Exhibit 99.1 and is incorporated by reference herein.Item 4 of the SCHEDULE 13D/A filed 2026-05-15
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-10-14 | Shah Capital Management intent stated | 7.3% | SCHEDULE 13D/A |
| 2025-11-12 | Shah Capital Management | 8.3% | SCHEDULE 13D/A |
| 2026-02-09 | State Street Corporation | 5.9% | SCHEDULE 13G |
| 2026-02-11 | Bank Of America Corp | 5.1% | SCHEDULE 13G |
| 2026-03-27 | The Vanguard Group | 0% | SCHEDULE 13G/A |
| 2026-04-08 | Shah Capital Management intent stated | 9.11% | SCHEDULE 13D/A |
| 2026-04-27 | Bank Of America Corp | 4.1% | SCHEDULE 13G/A |
| 2026-04-30 | Vanguard Capital Management | 5.09% | SCHEDULE 13G |
| 2026-05-15 | Shah Capital Management | 9.03% | SCHEDULE 13D/A |
| 2026-08-07 | State Street Corporation | 7.1% | SCHEDULE 13G |
Tools for this story
Each opens in a new tab, filled in for Novavax Inc. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.